Enzo Biochem, Inc.
IMMUNE MODULATION FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION

Last updated:

Abstract:

The invention provides methods for treating age-related macular degeneration by administering (i) peptide compositions, (ii) regulatory T-cells from the patient or a compatible donor, or (iii) a combination of regulatory T-cells and said peptide compositions. Also provided are methods for diagnosing age-related macular degeneration and monitoring its progression.

Status:
Application
Type:

Utility

Filling date:

13 Jun 2019

Issue date:

17 Oct 2019